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ABSTRACT 
Background  To improve the diagnostic accuracy for hepatic tumors on the liver surface, 
we investigated the usefulness of an indocyanine green-photodynamic eye (ICG-PDE) system 25 
by comparison with Sonazoid intraoperative ultrasonography (IOUS) in 117 patients. Hepatic 
segmentation by ICG-PDE was also evaluated. 
Methods  ICG was administered preoperatively for functional testing and images of the 
tumor were observed during hepatectomy using a PDE camera. ICG was injected into portal 
veins to determine hepatic segmentation. 30 
Results  Accurate diagnosis of liver tumors was achieved with ICG-PDE in 75% of 
patients, lower than with IOUS (94%). False-positive and false-negative diagnosis rates for 
ICG-PDE were 24% and 9%, respectively. New small HCCs were detected in 3 patients. The 
ICG fluorescent pattern in tumors was strong staining in 41%, weak staining in 13%, rim 
staining in 20% and no staining in 26%. Hepatocellular carcinoma predominantly showed 35 
strong staining (61%), while rim staining predominated in cholangiocellular carcinoma (60%) 
and liver metastasis (55%). Hepatic segmental staining was performed in 28 patients, proving 
successful in 89%.  
Conclusion  ICG-PDE is a useful tool for detecting the precise tumor location at the liver 
surface, identifying new small tumors, and determining liver segmentation for liver resection. 40 
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INTRODUCTION 
Hepatic resection is a useful option in the radical treatment of various liver carcinomas.1 45 
In the surgical procedure, radical resection without residual tumor is necessary to accomplish 
high curative rates.2 During hepatectomy, palpation and intraoperative ultrasonography 
(IOUS) are essential tools to determine tumor locations and identify small tumors undetected 
on preoperative imaging. Enhanced US has recently been applied to examine the vascular 
flow for detecting liver tumors or tumor morphology.3,4 The detection of liver malignancies 50 
by US has improved dramatically with the introduction of microbubble agents. Recent reports 
have clarified the utility of IOUS using Sonazoid microbubbles for intraoperative 
diagnosis.5,6 However, detection of small lesions less than 1 cm in diameter and differential 
diagnosis from cirrhotic nodules on the liver surface remains difficult with US.7 Other 
diagnostic modalities are therefore needed to facilitate diagnosis at the liver surface. 55 
Indocyanine green (ICG) has usually been used to examine hepatic functional reserve.8,9 
After intravenous administration, ICG immediately combines with serum protein, and this 
combined ICG is specifically taken up by the liver and immediately excreted into bile without 
being metabolized.10 In a normal liver, most ICG dissipates in the blood. ICG has also been 
applied to detect sentinel lymph nodes in cases of breast carcinoma, with detection using a 60 
new medical imaging system applying an infrared light detector, the ICG-photodynamic eye 
(PDE).11 Although near-infrared light cannot be seen with the naked eye, the distribution of 
subtle fluorescent materials in tissues can be precisely detected using a detector of 
near-infrared radiation, because the ICG accumulated in tissue fluoresces under excitation by 
light from a laser. Applying this approach to detect ICG fluorescence improves the specificity 65 
of ICG detection compared with dye injection detected on macroscopic observation.12 
ICG-PDE has also recently been applied to detect liver tumors during hepatectomy.13-17 ICG 
may remain in or around a liver tumor for a couple of days after administration and the 
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contrast between liver tumor and liver parenchyma can be marked. Accumulation of ICG 
might differ between histological types or levels of differentiation.13 As anatomical resection 70 
of the liver and post-hepatectomy complications are likely to affect patient survival,18-19 
visualization of the precise segmentation for resection and prevention of complications are 
important from an oncological perspective. With intravenous or intrabiliary injection of ICG, 
detection of segmental fluorescence, clarification of the biliary anatomy and identification of 
bile leakage at the transected liver becomes possible.20-22 However, the diagnostic accuracy, 75 
limitations and clinical applications of ICG-PDE have yet to be fully clarified. We 
hypothesized that ICG-PDE can improve the accuracy of diagnosing liver tumors at the liver 
surface and that ICG navigation surgery would be feasible as an alternative to blue-dye 
injection, or “tattooing”, for achieving anatomical hepatectomy.23 Accurate diagnosis of 
tumor location and adequate segmentectomy during surgery are important for achieving 80 
complete cure.  
The aim of the present preliminary study was thus to clarify various aspects of ICG-PDE 
imaging. For this purpose, we assessed the use of ICG-PDE in 117 patients with benign or 
malignant hepatobiliary diseases who underwent surgical resections by comparison with the 
conventional diagnostic tool of Sonazoid-IOUS, and examined the feasibility and limitations 85 
of this modality for tumor diagnosis. The possibility of applying ICG navigation to 
hepatectomy was also considered.  
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Patients and methods 90 
Patient background 
Study participants comprised 117 patients with hepatobiliary tumors who were scheduled 
for surgery and admitted to the Division of Surgical Oncology at Nagasaki University 
Hospital (NUH) between November 2009 and January 2014. In this study, all patients were 
also examined by Sonazoid-IOUS as a reference since 2009 after its approval by the Japanese 95 
health authorities. Liver tumors included hepatocellular carcinoma (HCC) in 56 patients, 
intrahepatic cholangiocarcinoma (CCC) in 12, colorectal liver metastasis in 36, hilar bile duct 
carcinoma in two, gall bladder carcinoma in four, neuroendocrine tumor in one and benign 
liver tumors in six (including hemangioma in two, angiomyolipoma in one, biliary adenoma 
in one, liver fibrosis in one and hematoma in one). Patients comprised 79 men and 38 women, 100 
with a mean (±standard deviation (SD)) age at the time of surgery of 68.6 ± 11.6 years (range, 
31-85 years). Background liver disease included normal liver in 42 patients, fatty liver in 
seven, cancer chemotherapy-associated liver dysfunction in 11, chronic viral hepatitis in 40, 
cirrhosis due to viral hepatitis in 15 and obstructive jaundice in two. Operative procedures 
included trisectionectomy, hemihepatectomy or central bisegmentectomy in 31 patients, 105 
segmentectomy or sectionectomy in 47, limited resection in 38 and other surgery in two 
(including tumor biopsy in both cases). All study protocols were approved by the Human 
Ethics Review Board at our institution. Informed consent for data collection was obtained 
from each patient during this period. Anesthesia data and patient data were retrieved from the 
NUH database. 110 
 
Procedure of Sonazoid-IOUS and ICG-PDE 
Examination of IOUS and contrast-enhanced IOUS was performed using a XarioTM XG 
system (Toshiba Medical Systems, Tokyo, Japan) and a microconvex probe (PVT-375BT, 3.5 
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MHz; Toshiba Medical Systems), as well as an intraoperative probe (PLT-705BTH, 7.5 MHz). 115 
All IOUS was performed by surgeons to help determine the need for hepatectomy. For tumors 
located at the liver surface, the liver was covered with warm saline to reduce the air gap 
between the probe and liver surface. An intravenous bolus injection of 0.5 ml of perflubutane 
microbubbles (Sonazoid) was administered via the peripheral vein at the time of making the 
laparotomy incision to observe Kupffer-phase images at 1-2 h after injection, because the 120 
microbubbles remain for a long time.5,6 Liver tumors were identified as low-contrast 
perfusion defects compared with normal liver parenchyma. Intraoperatively, viewing of the 
late Kupffer-phase images was first started and main liver tumors were clearly detected as 
perfusion defects, appearing as ill-defined low-echoic areas. Intratumor revascularization in 
the arterial phase was then examined and poor vascularization was confirmed by the 125 
reperfusion technique. 
ICG was intravenously injected 4-7 days before hepatectomy to examine the routine 
ICG retention rate at 15 min, in order to evaluate hepatic functional reserve, as a necessary 
step in deciding on operative indications.8,9 When ICG testing was performed over 14 days 
before hepatectomy, 10 ml of diluted ICG (0.5 mg/kg of ICG dissolved in distilled water) was 130 
intravenously injected the day before hepatectomy. During laparotomy, under dark conditions, 
a PDE camera system (Hamamatsu Photonics, Hamamatsu, Japan) (Fig. 1) was applied to 
detect ICG fluorescence. This system irradiated the ICG combined with serum protein with 
infrared light (wavelength, 750-830 nm). The excited ICG fluoresced at a wavelength of 845 
nm, which was detected by the PDE detector. First, to determine tumor location, the surface 135 
of the whole liver was observed. All liver tumors and lesions newly detected by ICG-PDE 
were also observed by palpation and Sonazoid-IOUS again.5 Small spots of strong 
fluorescence less than 5 mm in diameter identified by ICG-PDE were partially resected as 
biopsy specimens in the present study (Fig. 2A). The pattern of fluorescent on ICG-PDE for 
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liver tumors was defined as: 1) strong stain (Fig. 2B); 2) weak stain (Fig. 2C); 3) rim stain 140 
around the tumor (Fig. 2D); or 4) no stain. In this study, a false-positive result was defined as 
positive fluorescence on ICG-PDE of a non-tumorous lesion, and a false-negative result was 
defined as no fluorescence on ICG-PDE of a tumorous lesion. 
Subsequently, in cases requiring anatomical hepatic resection, 5 ml of ICG diluted with 
100 ml of distilled water (0.25 mg/ml) was intraoperatively injected into the portal vein 145 
supplying the estimated area for liver resection under IOUS. Accompanied by macroscopic 
findings for ICG dye and IOUS, the area of fluorescing liver was marked by diathermy (Fig. 
3A). After hepatic resection, resected tumors and surgical margins were observed for 
specimens and the amputated area of remnant liver. To detect bile duct leakage at the cut 
surface, 0.25 mg/ml of ICG was injected into the bile duct via the cystic duct and careful 150 
examination for tiny spots or extravasation of bile was performed at the cut surface (Fig. 3B). 
 
Statistical analysis 
All continuous data are expressed as mean ±SD. Data were compared between groups using 
one-way analysis of variance (ANOVA). The chi-square test was used to compare categorical 155 
variables. Two-tailed P values <0.05 were considered significant. SPSS for Windows version 
18.0 software (SPSS, an IBM Company, Chicago, IL) was used for all statistical analyses. 
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Results 160 
Feasibility and diagnosis of liver tumors by ICG-PDE 
Intraoperative ICG-PDE was able to be carried out for all patients without ICG-related side 
effects. Mean tumor size was 3.6±1.8 cm (range, 0.5-8.5 cm). Accurate diagnosis of benign 
and malignant liver tumors was achieved in 110 of 117 patients (94%) by Sonazoid-IOUS 
and 88 of 117 patients (75%) by ICG-PDE. A difference in diagnosis was seen between 165 
Sonazoid-IOUS and ICG-PDE in 27 of the 117 patients (24%). No significant relationship 
between tumor location and detectability of ICG-PDE was observed (data not shown). 
False-positive and false-negative diagnoses by Sonazoid-IOUS numbered three (2%) and 
seven (6%), while those by ICG-PDE numbered 28 (24%) and 10 (9%), respectively. Reasons 
for lesions being technically undetectable on ICG-PDE included depth of the tumor 170 
(fluorescence was not observed in deep lesions >10 mm from the liver surface due to the 
limitations of fluorescent permeability) in seven patients (5.6%).  
Diagnostic accuracy for malignant liver tumor in the 117 patients was compared between 
Sonazoid-IOUS and ICG-PDE. Sonazoid-IOUS diagnosed 109 of 111 malignant tumors and 
5 of 6 non-malignant tumors. Sensitivity, specificity, positive predictive value, negative 175 
predictive value and accuracy were 98%, 83%, 99%, 71% and 97%, respectively. ICG-PDE 
diagnosed 85 of 111 malignant tumors and 3 of 6 non-malignant tumors. Sensitivity, 
specificity, positive predictive value, negative predictive value and accuracy were 77%, 50%, 
97%, 10% and 75%, respectively. Single diagnostic accuracy for malignant liver tumors was 
higher for Sonazoid-IOUS than for ICG-PDE. 180 
The ICG fluorescent pattern in liver tumors was divided into four types, as follows: strong 
staining in 47 patients (41%); weak staining in 15 (13%); rim staining surrounding the tumor 
in 25 (20%); and no staining in 30 (26%). The relationship between the ICG fluorescent 
pattern of the tumor lesion and the type of liver tumor is shown in Table 1.  
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In benign tumors, angiomyolipoma with hypervascular enhancement showed strong ICG 185 
staining, while biliary adenoma with mild vascularity showed weak homogeneous staining. 
Cavernous hemangioma showed rim staining. Non-tumorous lesions showed no staining. All 
benign lesions were able to be diagnosed by ICG-PDE.  
In malignant tumors, ICG fluorescence was observed in 41 of 56 patients (74%) with 
HCC; strong staining was predominantly observed in these cases, representing 61%. Rim 190 
staining was observed in only one patient. ICG fluorescence was observed in 10 of 12 
patients (83%) with CCC; for these cases, rim staining was predominantly observed, 
representing 60%. Strong staining was observed in 30%. ICG fluorescence was observed in 
31 of the 36 patients (86%) with liver metastasis; these patients predominantly showed rim 
staining, representing 55%. Strong or weak staining was observed in 47%. One patient with 195 
neuroendocrine liver tumor with hypervascularity showed strong staining. In the gallbladder, 
one patient with liver bed invasion showed strong staining, but three other tumors did not 
show any staining. The two patients with bile duct carcinoma showed no staining without 
liver metastasis. 
ICG-PDE fluorescent patterns for accessory benign liver lesions in patients with 200 
malignant tumors are shown in Table 2. Liver cysts showed ICG fluorescence in 7 of 12 
lesions (58%), while small hemangioma showed fluorescence in 4 of 6 lesions (67%). Small 
spot fluorescence was observed in seven lesions and an ablated lesion showed rim staining. In 
cirrhotic liver, weaker, non-specific staining was seen in comparison with the fluorescence 
detectable in main tumors, possibly due to a delayed discharge of ICG into liver parenchyma. 205 
Bile leakage spot was observed in two cases (Fig. 2B). New small lesions of intrahepatic 
metastasis from the main HCC apparent only on ICG-PDE were observed in three patients. 
On the other hand, intrahepatic metastasis from the main HCC was not detected by ICG-PDE 
in four patients. Three patients showed visible tumor lesions between 5 and 8 mm in diameter. 
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A non-visible lesion 2 mm in diameter was histologically confirmed in the resected specimen 210 
from one patient. Strong fluorescence of macroscopic tumor thrombus in the portal trunk was 
achieved via the portal vein wall in two patients. Lymph node metastasis of CCC was not 
detected by ICG-PDE. 
 
Segmental visualization by fluorescent staining using ICG-PDE 215 
Hepatic segmental or sectional staining for ICG-PDE navigation hepatectomy was performed 
for 28 patients. The scheduled segmental staining could be performed in 25 patients (89%) 
for whom a burden of the posterior sector and caudate lobe could be counter-stained (the 
posterior sector was stained and the caudate lobe was not). The remaining three patients 
showed technical failure of scheduled segmental staining including caudate counter-staining. 220 
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Discussion 
ICG-PDE has recently been applied to detect lymph nodes via the lymphatic duct in the fields 
of breast and digestive surgery,11,24,25 and to detect vascular flow in other fields of 225 
surgery.12,26,27 The PDE system is thus useful to observe the dynamic changes of various 
materials inside the body. In the hepato-biliary-pancreatic field, application of ICG-PDE has 
also been attempted to detect the intrahepatic tumor location, hepatic segmentation, biliary 
leakage and status for biliary surgery.13-22,28 However, to the best of our knowledge, the 
usefulness and reliability of ICG-PDE in this field have not been fully clarified. From 230 
previous reports, the depth of tissue detectable by ICG-PDE might be less than 10 mm (no 
data or references shown), so this diagnosis may be applicable only at the liver surface or on 
cut surfaces of hepatic parenchyma. ICG that has combined with serum protein in the liver 
usually washes out within several hours, but remains trapped for a long period within liver 
tumors such as HCC, ICC, and metastatic liver carcinomas.13-22 In the case of ICG testing, 235 
ICG is specifically collected in the liver via hepatic blood flow and the hypervascular liver 
area shows marked staining. ICG is then metabolized in the hepatic cells and immediately 
excreted into bile. However, in hypervascular tumor lesions, ICG is trapped and excretion 
may be delayed for a long period. However, the mechanisms underlying retention in 
malignancies have not yet been clarified, although ICG might be trapped in cancer cells in 240 
cases of hypervascular tumors such as HCC.13 This type of lesion could thus be detected 
using a near-infrared ray detector in the ICG-PDE system.12  
Alternatively, Sonazoid-IOUS offers a powerful approach for imaging diagnosis to detect 
tumor distributions.5-7 Sonazoid became available as a contrast medium containing 
microbubbles in 2007, and has been widely applied for the diagnosis of liver tumors 245 
including HCC, CCC and liver metastasis.5-7,15,22 The introduction of this agent has markedly 
improved the accuracy of diagnosing liver tumors to levels similar to those of magnetic 
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resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.29 
Although even small lesions could be detected in deep areas of the liver by Sonazoid-IOUS, 
detection at the liver surface or on cut surfaces represent a blind spot for this approach.5 This 250 
modality has already been established as the conventional diagnostic tool at our institute. We 
therefore hypothesized that the combination of Sonazoid-IOUS and ICG-PDE would offer a 
more powerful diagnostic tool for the intraoperative detection of tumor distribution. However, 
the advantages and limitations of each modality should also be clarified. 
In the present series, all liver tumors could be detected by ICG-PDE. In 117 patients, we 255 
attempted both Sonazoid-US and ICG-PDE during hepatectomy to overcome the limitation of 
Sonazoid-IOUS alone. Occult metastatic lesions undetected on preoperative examinations 
and IOUS were expected to be detected by the new powerful diagnostic tool according to the 
hypothesis of the present study. As a result, the overall rate of accurate diagnosis by 
ICG-PDE was lower than that by Sonazoid-IOUS, because of the different fluorescent rates 260 
in various tumors, tumor depth, and the limited size of small tumors. Occult intrahepatic 
metastasis could be observed in only three patients and the clinical significance of additional 
ICG-PDE was very limited. With respect to the accurate diagnosis of malignant liver tumors, 
Sonazoid-IOUS was more reliable and available as the conventional diagnostic tool during 
hepatectomy according to our results. However, the aim of the present study was to clarify 265 
the diagnostic limitations of IOUS of the liver surface combined with ICG-PDE. From this 
perspective, our concept of a combination method might be useful in improving surgical 
results. 
According to recent reports, the fluorescent patterns of liver tumors vary among 
homogeneous strong staining, heterogeneous weak staining, staining surrounding the tumor 270 
or no staining.15-17 Such variation was confirmed in the present series. In hypervascular 
benign tumors, ICG fluorescence was strongly detected due to vascular retention. However, 
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in the non-structural area of nodular lesions, no fluorescence was observed. ICG-PDE might 
thus be useful for differentiation from non-tumorous lesions in the liver. Among the 
malignant lesions, hypervascular tumors such as HCC, some CCC and neuroendocrine 275 
tumors showed strong staining by ICG retention. In cases of liver tumor with strong 
fluorescence, residual tumor lesions at the resected edge were easily observed and some 
additional lesions could be completely resected. Among colorectal liver metastasis, 
vascularity was often observed around the tumor, so detecting the edge of the surgical 
margins might be difficult for colorectal tumors. We attempted ICG-PDE for adjacent 280 
malignancies, such as gallbladder carcinoma or bile duct carcinoma. However, ICG-PDE is 
not useful for detecting fluorescence of the main tumor or surrounding cancer metastasis, 
because of the low rate of fluorescence. Among accessory lesions, cysts and hemangiomas 
were identifiable from ICG-PDE, so a false-positive diagnosis must be ruled out. In benign 
cysts, fluorescence of ICG was caused by fluid retained in the cyst, but not by hemorrhage, 285 
and the precise mechanisms underlying this phenomenon have yet to be explained. In such 
accessory lesions with identification of biliary leakage spots and detection of portal vein 
thrombosis, the clinical usefulness of ICG-PDE has already been reported.17-22  
In patients with severe liver injury such as cirrhosis or those who underwent ICG 
administration within a few days, multiple false-positive fluorescent spots were observed. 290 
False-positive spots have also been previously reported observed in tumor diagnosis.16 This 
problem remains in patients with very poor liver function who may have undergone liver 
transplantation,30 but few problems of false-positive areas were seen in patients indicated for 
hepatectomy in the present study. As shown from our results, false-positive areas were shown 
as tiny spots that were readily distinguished from true liver lesions. Some patients 295 
occasionally undergo ablation therapy or transarterial chemoembolization (TACE) prior to 
the hepatectomy. This results in alteration of the echogenicity of the treated area, appearing 
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as hypoechoic lesions. Accurate differentiation between necrotic lesions and viable tumors 
may then be difficult by conventional US. However, early vascularization in the tumor area 
or surrounding region is a sign of tumor viability.31 In the resected area after hepatectomy, 300 
subtle remnant tumor cannot be macroscopically observed intraoperatively. The cut surface 
under ICG-PDE showed spotted areas of remnant tumor confirmed by histological findings in 
some of our cases.  
Anatomical resection of the liver can be needed under various circumstances, as described 
above.18 Another application of ICG-PDE is segmentation by portal injection of ICG.18-22 305 
Tattooing or blue-dye segmentation has been applied to achieve anatomical segmentectomy 
or sectorectomy.23 With those methods, visualization of the stained area is sometimes difficult 
and the dye soon washes out. Segmentation using ICG-PDE might enable clearer detection, 
although detailed comparisons were not performed in the present study. The usefulness of 
ICG-PDE segmentation compared with the conventional dye method has also not yet been 310 
reported. The present series also applied ICG-PDE segmentation as a counter-stain for 
non-stained areas to confirm the segment to be resected in the caudate lobe or segment 8.  
By injecting ICG into the bile duct, biliary fistula could be sensitively detected using the 
ICG-PDE system, as described in previous reports.18,28 In the present series, unexpected areas 
of biliary fistula could be detected by testing for bile leakage just after hepatectomy in a few 315 
cases. In one patient who underwent right hepatectomy, amputated-type biliary fistula in the 
remnant left caudate lobe that could not be controlled by chemical ablation or fibrin glue was 
able to be detected by ICG-PDE during reoperation for fixation of biliary fistula. This lesion 
was locally ablated and well-controlled after reoperation.  
Future applications of ICG-PDE have recently been proposed. One approach is application to 320 
tumor detection during laparoscopic hepatectomy.32 Development of a laparoscopy-exclusive 
ICG-PDE system is expected. Another application is use in photodynamic therapy (PDT) to 
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treat ICG-accumulating liver tumors by laser excitation using light of different wavelengths.33 
At present, although sufficient effects of PDT using ICG-PDE have not been confirmed, a 
recent report by Kaneko et al. showed the possibility of PDT with ICG-PDE for liver cancer 325 
in an animal model.34 Such a laser-applied tools could be improved for future approaches. In 
conclusion, we have demonstrated that ICG-PDE allows easy examination of the tumor 
distribution, including identification of new lesions or remnant cancer at the liver surface or 
cut edge after hepatectomy, for detection of the extent of portal trunk tumor thrombosis of 
HCC, for detection of unexpected biliary fistula, and for determination of the extent of the 330 
area to be resected by portal vein injection as a method of ICG navigation, potentially 
facilitating decision-making for hepatic resection. This new imaging modality could become 
a standard procedure combined with enhanced IOUS or palpation in patients with liver 
tumors who undergo hepatectomy. 
 335 
Conflict of interest statement 
The authors declare that they have no conflicts of interest. 
 
Nanashima A et al., Page 16 
REFERENCES 340 
1. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. 
Gastroenterology 2004;127:S248-260.  
2. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis 
after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 
2003;12:165-192  345 
3.  Torzilli G, Makuuchi M. Intraoperative ultrasonography in liver cancer. Surg Oncol Clin 
N Am 2003;12:91-103. 
4.  Poon RT. Recent advances in techniques of liver resection. Surg Technol Int 
2004;13:71-77.  
5.  Nanashima A1, Tobinaga S, Abo T, et al. Usefulness of sonazoid-ultrasonography during 350 
hepatectomy in patients with liver tumors: A preliminary study. J Surg Oncol. 
2011;103:152-157. 
6.  Nakano H, Ishida Y, Hatakeyama T, et al. Contrast-enhanced intraoperative 
ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in 
patients with colorectal liver metastases. World J Gastroenterol. 2008;14:3207-3211. 355 
7.  Numata K, Morimoto M, Ogura T, et al. Ablation therapy guided by contrast-enhanced 
sonography with Sonazoid for hepatocellular carcinoma lesions not detected by 
conventional sonography. J Ultrasound Med 2008;27:395-406. 
8.  Takasaki T, Kobayashi S, Suzuki S, et al. Predetermining postoperative hepatic function 
for hepatectomies. Int. Surg. 1980;65:309-313 360 
9.  Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic 
functional reserve as a guide to decision-making in resection surgery for hepatic tumors. 
Hepatology 1997;26:1176-1181. 
Nanashima A et al., Page 17 
10. Wilson SA, Tavendale R, Hewick DS. The biliary elimination of amaranth, indocyanine 
green and nitrazepam in germ-free rats. Biochem Pharmacol. 1985;34:857-863. 365 
11. Hojo T, Nagao T, Kikuyama M, et al. Evaluation of sentinel node biopsy by combined 
fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210-213. 
12. Unno N, Suzuki M, Yamamoto N, et al. Indocyanine green fluorescence angiography for 
intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg. 
2008;35:205-7. 370 
13. Gotoh K, Yamada T, Ishikawa O, et al. A novel image-guided surgery of hepatocellular 
carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 
2009;100:75-79. 
14. Uchiyama K, Ueno M, Ozawa S, et al. Combined use of contrast-enhanced intraoperative 
ultrasonography and a fluorescence navigation system for identifying hepatic metastases. 375 
World J Surg. 2010;34:2953-2959. 
15. Kasuya K, Sugimoto K, Kyo B, et al. Ultrasonography-guided hepatic tumor resection 
using a real-time virtual sonography with indocyanine green navigation (with videos). J 
Hepatobiliary Pancreat Sci. 2011;18:380-385. 
16. Ishizuka M, Kubota K, Kita J, et al. Intraoperative observation using a fluorescence 380 
imaging instrument during hepatic resection for liver metastasis from colorectal cancer. 
Hepatogastroenterology. 2012;59:90-2. 
17 Peloso A, Franchi E, Canepa MC, et al. Combined use of intraoperative ultrasound and 
indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. 
HPB (Oxford). 2013;15:928-34. 385 
18 Eguchi S, Kanematsu T, Arii S, et al.; Liver Cancer Study Group of Japan. Comparison of 
the outcomes between an anatomical subsegmentectomy and a non-anatomical minor 
Nanashima A et al., Page 18 
hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. 
Surgery. 2008;143:469-75. 
19 Nanashima A1, Abo T, Hamasaki K, et al. Perioperative non-tumorous factors associated 390 
with survival in HCC patients who underwent hepatectomy. Anticancer Res. 
2011;31:4545-51. 
20. Kaibori M, Ishizaki M, Matsui K, et al. Intraoperative indocyanine green fluorescent 
imaging for prevention of bile leakage after hepatic resection. Surgery. 2011;150:91-98. 
21. Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence 395 
navigation system with indocyanine green for anatomical hepatic resection. World J Surg. 
2008;32:1763-1767. 
22. Uchiyama K, Ueno M, Ozawa S, et al. Combined intraoperative use of contrast-enhanced 
ultrasonography imaging using a sonazoid and fluorescence navigation system with 
indocyanine green during anatomical hepatectomy. Langenbecks Arch Surg. 400 
2011;396:1101-1107. 
23. Takayama T, Makuuchi M, Watanabe K, et al. A new method for mapping hepatic 
subsegment: counterstaining identification technique. Surgery. 1991;109:226-9. 
24. Noura S, Ohue M, Seki Y, et al. Feasibility of a lateral region sentinel node biopsy of 
lower rectal cancer guided by indocyanine green using a near-infrared camera system. 405 
Ann Surg Oncol. 2010;17:144-151. 
25. Miyashiro I, Hiratsuka M, Kishi K, et al. Intraoperative diagnosis using sentinel node 
biopsy with indocyanine green dye in gastric cancer surgery: an institutional trial by 
experienced surgeons. Ann Surg Oncol. 2013;20:542-546. 
26. Okusanya OT1, Madajewski B, Segal E, et al. small portable interchangeable imager of 410 
fluorescence for fluorescence guided surgery and research. Technol Cancer Res Treat. 
2013. [Epub ahead of print] 
Nanashima A et al., Page 19 
27. Buretta KJ, Brat GA, Christensen JM, et al. Near-infrared lymphography as a minimally 
invasive modality for imaging lymphatic reconstitution in a rat orthotopic hind limb 
transplantation model. Transpl Int. 2013;26:928-937. 415 
28. Spinoglio G, Priora F, Bianchi PP, et al. Real-time near-infrared (NIR) fluorescent 
cholangiography in single-site robotic cholecystectomy (SSRC): a single-institutional 
prospective study. Surg Endosc. 2013;27:2156-2162. 
29. Kudo M, Matsui O, Sakamoto M, et al. Role of gadolinium- ethoxybenzyl- 
diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the 420 
management of hepatocellular carcinoma: consensus at the Symposium of the 48th 
Annual Meeting of the Liver Cancer Study Group of Japan. Oncology. 2013;84:21-27. 
30. Tanaka T, Takatsuki M, Hidaka M, et al. Is a fluorescence navigation system with 
indocyanine green effective enough to detect liver malignancies? J Hepatobiliary 
Pancreat Sci. 2013 doi: 10.1002/jhbp.17. [Epub ahead of print] 425 
31. Muramatsu Y, Takayasu K, Moriyama N, et al. Peripheral low-density area of hepatic 
tumors: CT-pathologic correlation. Radiology. 1986;160:49-52. 
32. van der Pas MH, Ankersmit M, Stockmann HB, et al. Laparoscopic sentinel lymph node 
identification in patients with colon carcinoma using a near-infrared dye: description of a 
new technique and feasibility study. J Laparoendosc Adv Surg Tech A. 2013;23:367-371. 430 
33. Wang JD, Shen J, Zhou XP, et al. Optimal treatment opportunity for mTHPC-mediated 
photodynamic therapy of liver cancer. Lasers Med Sci. 2013;28:1541-1548. 
34. Kaneko J, Inagaki Y, Ishizawa T, et al. Photodynamic therapy for human 
hepatoma-cell-line tumors utilizing biliary excretion properties of indocyanine green. J 
Gastroenterol. 2014;49:110-116. 435 
Nanashima A et al., Page 20 
FIGURE LEGENDS 
Fig. 1 The ICG-PDE camera system. 
 
Fig. 2 Representative image of the ICG-PDE system during operation. A small (less than 5 440 
mm in diameter), strongly fluorescing spot on ICG-PDE (A). The pattern of ICG-PDE 
fluorescence in liver tumors was defined as: 1) strong stain (B); 2) weak stain (C); 3) rim 
staining around the tumor (D); or 4) no stain. B and C show sections from a resected 
specimen. 
 445 
Fig. 3 Findings of ICG dye injection in the portal vein for the targeted segment. The 
fluorescing area of liver (segments 7 and 8) show marked ICG fluorescence (A). To detect 
bile duct leakage by ICG injection into the bile duct, tiny spots or extravasation of bile were 
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TABLE 1. ICG fluorescent pattern and main liver tumor by ICG-PDE 














 Local fibrosis  































 Hepatocellular carcinoma 
 Cholangiocellular carcinoma 
 Colorectal liver metastasis  
 Neuroendocrine tumor 
Gallbladder carcinoma* 
 
No liver metastasis 





































* One patient with liver bed invasion 
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TABLE 2. ICG fluorescent pattern and accessory liver tumors by ICG-PDE 5 





 Simple cyst 
 Small hemangioma 
 
Non-tumor lesion 
 Cirrhotic small nodule  
 Ablated lesion 

















 Intrahepatic metastasis of HCC 
 Portal trunk thrombosis of HCC 
 Adrenal gland metastasis of HCC 










* Rim stain  
 
 
